|
Net sales increased by 7.3% to Rs 1,092.98 crore in quarter ended December 2021 from Rs 1,018.44 crore recorded in the same period last year. Profit before tax fell nearly 15% to Rs 287.50 crore in quarter ended December 2021 versus quarter ended December 2020.
The FMCG firm said profitability was down due to lower advertising and promotion investments on brand building in the base period due to the pandemic and commodity cost inflation. For the quarter, both Feminine Care and Health Care businesses grew ahead of their categories.
Madhusudan Gopalan, MD of Procter & Gamble Hygiene and Health Care said, “In a challenging market environment, we have delivered strong sales growth behind strong brand fundamentals and improved market execution. As the industry faces commodity inflation challenges, we continue to focus on improving productivity by leveraging advertising and promotion analytics, strengthening our product mix and driving supply chain efficiency to drive balanced top and bottom-line growth. We will continue to focus on our strategy of driving superiority and productivity, invest in brand building, enabled by the strength of our organization and culture.”
Meanwhile, the company's board of directors declared an interim dividend of Rs 95 per every equity share. The record date for the dividend will be 9 February 2022.
Procter & Gamble Hygiene & Health Care is engaged in manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements.
Shares of Procter & Gamble Hygiene & Health Care were trading 0.11% lower at Rs 14,800 on BSE.
|